|
|
||||||||
Journal of Lipid Research, Vol 28, 778-786, Copyright © 1987 by Lipid Research, Inc.
BY Ishida, J Frolich and CJ Fielding
A quantitative solid phase immunoassay has been developed for the
determination of the mass of electrophoretically separated prebeta
apolipoprotein A-I (apoA-I) in human plasma. Conditions have been
identified for the quantitative transfer and immunoblotting of the
apolipoprotein in the absence of organic solvents or detergents. In
normolipidemic plasma, the prebeta-migrating fraction of apoA-I represented
4.2 +/- 1.8% of total apoA-I (61 +/- 26 micrograms of apoA- I per ml of
plasma). Significantly higher levels were found in hypercholesterolemia of
genetic origin, in primary and secondary hypertriglyceridemia, and in
congenital lecithin:cholesterol acyltransferase deficiency. In all cases
prebeta-migrating apoA-I consisted in large part of low molecular weight
lipoprotein species, compared to the size of the major, alpha-migrating
apoA-I fraction.
ARTICLES
Prebeta-migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. T. Duong, G. L. Weibel, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips Characterization and properties of pre{beta}-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I J. Lipid Res., May 1, 2008; 49(5): 1006 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P F Dullaart, A. K Groen, G. M Dallinga-Thie, R. de Vries, W. J Sluiter, and A. van Tol Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol Eur. J. Endocrinol., January 1, 2008; 158(1): 53 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okazaki, S. Usui, A. Fukui, I. Kubota, and H. Tomoike Component Analysis of HPLC Profiles of Unique Lipoprotein Subclass Cholesterols for Detection of Coronary Artery Disease Clin. Chem., November 1, 2006; 52(11): 2049 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kontush and M. J. Chapman Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Soderlund, A. Soro-Paavonen, C. Ehnholm, M. Jauhiainen, and M.-R. Taskinen Hypertriglyceridemia is associated with pre{beta}-HDL concentrations in subjects with familial low HDL J. Lipid Res., August 1, 2005; 46(8): 1643 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzuki, H. Wada, S. Maeda, K. Saito, S. Minatoguchi, K. Saito, and M. Seishima Increased Plasma Lipid-Poor Apolipoprotein A-I in Patients with Coronary Artery Disease Clin. Chem., January 1, 2005; 51(1): 132 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakabayashi, K. Yamauchi, M. Sugano, K. Sano, M. Tozuka, and H. Hidaka Degradation of Pre-{beta}-High Density Lipoproteins and Their Binding Activity to Human Blood Monocytes Ann. Clin. Lab. Sci., July 1, 2004; 34(3): 287 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Lee, L. Lanningham-Foster, E. Y. Boudyguina, T. L. Smith, E. R. Young, P. L. Colvin, M. J. Thomas, and J. S. Parks Pre{beta} high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice J. Lipid Res., April 1, 2004; 45(4): 716 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-A. Rye and P. J. Barter Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 421 - 428. [Abstract] [Full Text] |
||||
![]() |
M. N. Nanjee and E. A. Brinton Very Small Apolipoprotein A-I-containing Particles from Human Plasma: Isolation and Quantification by High-Performance Size-Exclusion Chromatography Clin. Chem., February 1, 2000; 46(2): 207 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Obici, V. Bellotti, P. Mangione, M. Stoppini, E. Arbustini, L. Verga, I. Zorzoli, E. Anesi, G. Zanotti, C. Campana, et al. The New Apolipoprotein A-I Variant Leu174 -> Ser Causes Hereditary Cardiac Amyloidosis, and the Amyloid Fibrils Are Constituted by the 93-Residue N-Terminal Polypeptide Am. J. Pathol., September 1, 1999; 155(3): 695 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miida, F. Yamazaki, M. Sakurai, R. Wada, T. Yamadera, K. Asami, M. Hoshiyama, A. Tanaka, K. Inano, and M. Okada The Apolipoprotein E Content of HDL in Cerebrospinal Fluid Is Higher in Children than in Adults Clin. Chem., August 1, 1999; 45(8): 1294 - 1296. [Full Text] [PDF] |
||||
![]() |
P. M. O'Connor, B. R. Zysow, S. A. Schoenhaus, B. Y. Ishida, S. T. Kunitake, J. M. Naya-Vigne, P. N. Duchateau, R. F. Redberg, S. J. Spencer, S. Mark, et al. Prebeta-1 HDL in plasma of normolipidemic individuals: influences of plasma lipoproteins, age, and gender J. Lipid Res., March 1, 1998; 39(3): 670 - 678. [Abstract] [Full Text] |
||||
![]() |
M. Sugano, N. Makino, S. Sawada, S. Otsuka, M. Watanabe, H. Okamoto, M. Kamada, and A. Mizushima Effect of Antisense Oligonucleotides against Cholesteryl Ester Transfer Protein on the Development of Atherosclerosis in Cholesterol-fed Rabbits J. Biol. Chem., February 27, 1998; 273(9): 5033 - 5036. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Duverger, C. Viglietta, L. Berthou, F. Emmanuel, A. Tailleux, L. Parmentier-Nihoul, B. Laine, C. Fievet, G. Castro, J. C. Fruchart, et al. Transgenic Rabbits Expressing Human Apolipoprotein A-I in the Liver Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1424 - 1429. [Abstract] [Full Text] |
||||
![]() |
D. L. Sparks, W. S. Davidson, S. Lund-Katz, and M. C. Phillips Effects of the Neutral Lipid Content of High Density Lipoprotein on Apolipoprotein A-I Structure and Particle Stability J. Biol. Chem., November 10, 1995; 270(45): 26910 - 26917. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murakami, S. Michelagnoli, R. Longhi, G. Gianfranceschi, F. Pazzucconi, L. Calabresi, C. R. Sirtori, and G. Franceschini Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1819 - 1828. [Abstract] [Full Text] |
||||
![]() |
C. Sass, L.-M. Giroux, S. Lussier-Cacan, J. Davignon, and A. Minnich Unexpected Consequences of Deletion of the First Two Repeats of the Ligand-binding Domain from the Low Density Lipoprotein Receptor J. Biol. Chem., October 20, 1995; 270(42): 25166 - 25171. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wang, D. L. Silver, P. Costet, and A. R. Tall Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1 J. Biol. Chem., October 13, 2000; 275(42): 33053 - 33058. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |